- Home
- MGTX vs OMDA Comparison
MGTX vs OMDA Comparison
Compare MGTX & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGTX | OMDA |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | 868 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 610.1M | 711.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGTX | OMDA |
|---|---|---|
| Price | $7.58 | $14.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $23.83 | ★ $24.00 |
| AVG Volume (30 Days) | 297.7K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,279,000.00 | N/A |
| Revenue This Year | N/A | $22.07 |
| Revenue Next Year | $569.48 | $19.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 137.42 | N/A |
| 52 Week Low | $4.73 | $10.28 |
| 52 Week High | $9.73 | $26.92 |
Technical Indicators
Market Signals| Indicator | MGTX | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 56.99 |
| Support Level | $7.23 | $10.28 |
| Resistance Level | $7.50 | $16.93 |
| Average True Range (ATR) | 0.36 | 0.80 |
| MACD | 0.02 | 0.24 |
| Stochastic Oscillator | 59.32 | 75.47 |
Price Performance
Historical ComparisonAbout MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About OMDA Omada Health Inc.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.